New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
07:41 EDTOSIR, SMA, CNMD, GMED, BONE, NUVA, MDXG, AXGN, BAXS, SNN, RTIX, ANIKCanaccord to hold a conference
Musculoskeletal Conference is being held in New Orleans, Louisiana on March 11.
News For GMED;ANIK;AXGN;CNMD;RTIX;MDXG;SMA;SNN;NUVA;OSIR;BAXS;BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
16:30 EDTRTIXRTI Surgical announces agreement with Oxford Performance Materials
RTI Surgical announced a new agreement with Oxford Performance Materials, or OPM, a pioneer in advanced materials and additive manufacturing for biomedical applications. The agreement, effective Feb. 4, 2016, grants RTI an exclusive license to OPM's OsteoFab technology platform for spinal applications in all U.S. markets. OsteoFab is a next-generation implant manufacturing process that builds implantable medical devices, layer-by-layer, using only laser light and OPM's OXPEKK polymer. The OsteoFab process and OXPEKK material combine to create implants that are designed to enable bone ongrowth. OXPEKK is a proprietary high-performance biocompatible polymer formulation from OPM, designed for medical applications. This strong, pure, radiolucent, hydrophilic, load-bearing material boasts a successful history in orthopedic implant applications. Under the agreement, OPM will manufacture RTI's spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.
16:10 EDTNUVANuVasive sees Ellipse acquisition accretive to 2016 EPS by 1c
Sees acquisition accelerating NuVasive revenue growth to high single-digits in 2016.
16:09 EDTNUVANuVasive to selectively explore M&A opportunities
"Very selectively, we also intend to explore compelling inorganic opportunities that add value, such as today's completion of the acquisition of Ellipse Technologies, and reinforce our focus on transformative spine solutions," the company said.
16:08 EDTNUVANuVasive sees FY16 adjusted EPS $1.48, consensus $1.49
Sees FY16 revenue $923M, consensus $881.1M.
16:07 EDTNUVANuVasive reports Q4 adjusted EPS 35c, consensus 31c
Reports Q4 revenue $215.3M, consensus $215.27M.
10:01 EDTSNNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARM Holdings (ARMH) downgraded to Underperform from Market Perform at Bernstein... Apollo Investment (AINV) downgraded to Market Perform from Outperform at JMP Securities... Cabot Microelectronics (CCMP) downgraded to Neutral from Buy at Citi... Caesarstone (CSTE) downgraded to Equal Weight from Overweight at Barclays... Capital One (COF) downgraded to Neutral from Buy at BofA/Merrill... Discover (DFS) downgraded to Neutral on potential US slow-down at BofA/Merrill... Douglas Emmett (DEI) downgraded at Stifel... E.ON AG (EONGY) downgraded to Sell from Hold at Berenberg... Flowers Foods (FLO) downgraded on disappointing results at SunTrust... HCP (HCP) downgraded at Stifel... International Flavors (IFF) downgraded to Hold from Buy at Deutsche Bank... LinnCo (LNCO) downgraded to Sell from Hold at Stifel... LivePerson (LPSN) downgraded to Neutral from Buy at Roth Capital... MasterCard (MA) downgraded to Neutral from Buy at BofA/Merrill... Matrix Service (MTRX) downgraded to Sector Weight from Overweight at KeyBanc... Prospect Capital (PSEC) downgraded to Underperform at Raymond James... RWE AG (RWEOY) downgraded to Sell from Hold at Berenberg... Regions Financial (RF) downgraded to Equal Weight from Overweight at Morgan Stanley... Rush Enterprises (RUSHA) downgraded to Market Perform at Raymond James... Smith & Nephew (SNN) downgraded to Neutral at UBS... SolarCity (SCTY) downgraded to Equal Weight from Overweight at Barclays... Sotheby's (BID) downgraded on weak art market at Stifel... SunEdison Semiconductor (SEMI) downgraded to Sell from Neutral at Citi... Sunrun (RUN) downgraded to Equal Weight from Overweight at Barclays... Synovus (SNV) downgraded to Underweight from Equal Weight at Morgan Stanley... Tenaris (TS) downgraded to Underweight from Neutral at JPMorgan... Twitter (TWTR) downgraded to Hold from Buy at Topeka... Visa (V) downgraded to Neutral on possible US slow-down at BofA/Merrill... W.P. Carey (WPC) downgraded to Equalweight from Overweight at Capital One... Wendy's (WEN) downgraded to Neutral from Overweight at JPMorgan.
08:21 EDTSNNSmith & Nephew downgraded to Neutral at UBS
Subscribe for More Information
07:21 EDTSNNSmith & Nephew downgraded to Neutral from Buy at UBS
07:17 EDTGMEDLeerink to hold a conference
Subscribe for More Information
February 4, 2016
07:25 EDTOSIROsiris price target lowered to $4 from $8 at Brean Capital
Subscribe for More Information
February 3, 2016
16:34 EDTOSIROsiris appoints Chief Business OfficerDwayne Montgomery as Interim CEO
Subscribe for More Information
February 2, 2016
11:03 EDTOSIROsiris price target lowered to $18.50 from $28 at Piper Jaffray
Subscribe for More Information
08:01 EDTOSIROsiris announces 100% Medicare coverage for Grafix
Subscribe for More Information
February 1, 2016
14:28 EDTSNNStryker deal for Smith & Nephew now unlikely, says Piper Jaffray
Subscribe for More Information
12:13 EDTSNNOn The Fly: Top stock stories at midday
Stocks on Wall Street were lower at midday, but off their worst levels of the day, as oil is once again being weighed on by worries of slower growth in China. Several M&A announcements helped fuel speculation that deal-making may be set to pick up, but the headwinds of lower oil prices and weak economic data are outweighing that potential boost and keeping stocks in the red to start the month. ECONOMIC EVENTS: In the U.S., personal income rose 0.3% in December, versus expectations for an increase of 0.2%, while spending was flat, versus expectations for an increase of 0.1%. Markit's manufacturing purchasing managers index for January dipped to 52.4 in the final January reading, down from the 52.7 flash reading and the below the 52.6 reading that was expected. The Institute for Supply Management's manufacturing index for January came in at 48.2, below the 48.4 that analysts expected. Construction spending rose 0.1% in December, which was weaker than the 0.6% increase that was forecast. In China, the statistics bureau's official manufacturing purchasing managers index fell to 49.4 in January from 49.7 in December. The private Caixin manufacturing PMI edged up to 48.4 from 48.2 in the prior reading, but both figures still remain in contraction territory. In Europe, Markit's manufacturing PMI for the euro zone dropped to 52.3 from December's 53.2, in-line with the earlier flash estimate. COMPANY NEWS: Shares of Twitter (TWTR) advanced 9% after tech reporter Jessica Lessin said private equity firm Silver Lake and investor Marc Andreessen have "considered some sort of deal" for the microblog service operator. Lessin noted in the report published on her site, The Information, that she did not know if deal talks are "active" now between Andreessen, Silver Lake and Twitter... Alere (ALR) surged 45% to $54 per share near midday after Abbott (ABT) agreed to acquire the company for $56 per share at a total expected equity value of $5.8B. In other Monday M&A news, Questar (STR) rose 22% after Dominion Resources (D) agreed to acquire it for $25 per share, or about $4.4B, and assume Questar's outstanding debt. Meanwhile, Stryker (SYK) announced a deal to acquire Sage Products for $2.775B in cash. The buyers' shares did not fare as well in the wake of the deal announcements, as Abbott slipped 0.5%, Dominion dipped 1% and Stryker fell 1%. Also lower were shares of Smith & Nephew (SNN), which slid fractionally as investors may have been concerned that Stryker's deal decreases the likelihood that it will come after S&N. Additionally, Smith & Nephew announced that its CEO Olivier Bohuon has been diagnosed with a "highly treatable" form of cancer. MAJOR MOVERS: Among the notable gainers was Lumber Liquidators (LL), which gained 8.5% after a judge accepted the company's $10M plea deal to settle timber source crime charges, according to media reports. Also higher was Chipotle (CMG), which rose 5.5% after The Wall Street Journal reported that the Centers for Disease Control and Prevention is expected to formally declare the end to its E.coli outbreak as soon as today. In addition, Sysco (SYY) and Aetna (AET) were up 7% and 2%, respectively, after reporting quarterly earnings. Among the noteworthy losers was Nokia (NOK), which fell 12% after it forecasted how much revenue it expects to gain from its IP portfolio after its patent deal with Samsung (SSNLF) and its shares were downgraded at Canaccord and BofA Merrill Lynch. Also lower was GoPro (GPRO), which was slid 5% after analysts from Piper Jaffray and Citi predicted that the company's guidance to be issued this week will disappoint investors. In addition, Roper Technologies (ROP) and ImmunoGen (IMGN) were down 6.5% and 5.7%, respectively, after reporting quarterly earnings. INDEXES: Near midday, the Dow was down 56.40, or 0.34%, to 16,409.90, the Nasdaq was down 12.25, or 0.27%, to 4,601.70, and the S&P 500 was down 6.51, or 0.34%, to 1,933.73.
08:26 EDTSNNSmith & Nephew reports CEO diagnosed with 'highly treatable' cancer
Smith & Nephew announced that Olivier Bohuon, Chief Executive Officer, has been diagnosed with a highly treatable form of cancer. "Olivier will remain Chief Executive Officer and be actively involved in running the Company through much of his treatment period, which will begin later this month. The treatment will include chemotherapy, and is expected to be completed by late autumn. The Board has approved provisional governance procedures to ensure the effective operation of Smith & Nephew during the treatment period, including Chairman Roberto Quarta providing executive oversight if required," the company stated.
January 29, 2016
10:06 EDTMDXGBlackRock increases passive stake in MiMedx to 9.1% from 5.1%
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use